{"altmetric_id":14766424,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"total":{"posts_count":61},"news":{"unique_users_count":60,"unique_users":["finanz_nachrichten","stock_nod_quotes","pr_newswire","yahoo_finance_usa","wall_street_online_denmark","ticker_tech","khq","the_state_journal","kait_tv","wistv","wltz","wmc_action_news_5","walb","wrcb_tv","cleveland_19","wtvm","48_waff","abc_7_news_kswo","wfmj","wmbf_news","fox_14_news","fox_wilmington","nbc12","news_channel","kltv","hawaii_news_now","wave_3_news","wtoc","nbc_right_now_kndu_25","pr_newswire_uk","wtol","wflx_fox_29","wdrb","cw_richmond","kfve_the_home_team","bioportfolio","14_news","tucson_news_now","abc_40","kten","newswest9","wboc_16","news_9","wsfa","wlox","kuam","ksla_news_12","wand_17","south_carolina_news_now","kusi_news","news_channel_6","ktre","newson6","klkn_tv_eyewitness_news","cbs8","mississippi_news_now","fresh_news","wdam_tv","kplc_7_news","2_news"],"posts_count":61}},"citation":{"authors":["Shilpa Gupta","Neeraj Agarwal"],"doi":"10.17925\/ohr.2016.12.02.82","first_seen_on":"2016-12-15T12:11:54+00:00","issns":["2052-3815"],"issue":"02","journal":"Oncology & Hematology Review (US)","last_mentioned_on":1481820190,"links":["http:\/\/dx.doi.org\/10.17925\/OHR.2016.12.02.82"],"pubdate":"2016-01-01T00:00:00+00:00","startpage":"82","title":"Cancer Immunotherapy with Interleukin-2\u2014Current Status and Future Developments","type":"article","volume":"12"},"altmetric_score":{"score":467,"score_history":{"1y":467,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":467},"context_for_score":null},"demographics":[],"posts":{"news":[{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28928915319&p=1pl&v=1&x=vnaL2tXW8fwtsTGGPC-PJA","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:01:00+00:00","summary":"\/PRNewswire\/ -- Shilpa Gupta, Neeraj Agarwal, Oncology & Hematology Review, 2016;12(2):82-8,https:\/\/doi.org\/10.17925\/OHR.2016.12.02.82 (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review\u2026","author":{"name":"Finanz Nachrichten","url":"http:\/\/www.finanznachrichten.de","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/853\/normal\/Screen_Shot_2016-01-27_at_11.54.22.png?1453895724"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28928923451&p=1pl&v=1&x=ObpAi-8PNL3-AXDCVhZ4Mw","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:00:00+00:00","summary":"LONDON Shilpa Gupta Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-access article is available here: https:\/\/doi.org\/10.17925\/OHR.2016.12.02.82 Disclosure\u2026","author":{"name":"Stock Nod: Quotes","url":"http:\/\/quotes.stocknod.com\/stocknod","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/671\/normal\/Screen_Shot_2016-01-26_at_13.59.47.png?1453816868"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28928923571&p=1pl&v=1&x=F2e8MfTK_NizLAsiU9C7Jg","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:00:00+00:00","summary":"(Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta discusses high-dose interleukin-2 (HD IL-2), which has been in clinical\u2026","author":{"name":"PR Newswire","url":"http:\/\/www.prnewswire.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/545\/normal\/Screen_Shot_2016-01-06_at_16.29.18.png?1452097789"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28928946259&p=1pl&v=1&x=Qhm2bC77K1gGE6QD9H5gLg","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:00:00+00:00","summary":"\/PRNewswire\/ -- Shilpa Gupta, Neeraj Agarwal, Oncology & Hematology Review, 2016;12(2):82-8, https:\/\/doi.org\/10.17925\/OHR.2016.12.02.82 (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review\u2026","author":{"name":"Yahoo! Finance USA","url":"http:\/\/finance.yahoo.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/620\/normal\/Screen_Shot_2016-01-07_at_10.14.50.png?1452161734"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28928949734&p=1pl&v=1&x=IwGVNct7D7U6MqKAssGP8Q","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:00:00+00:00","summary":"\/PRNewswire\/ -- Shilpa Gupta, Neeraj Agarwal, Oncology & Hematology Review, 2016;12(2):82-8, https:\/\/doi.org\/10.17925\/OHR.2016.12.02.82 (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review \u2026","author":{"name":"Yahoo! Finance USA","url":"http:\/\/finance.yahoo.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/620\/normal\/Screen_Shot_2016-01-07_at_10.14.50.png?1452161734"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28928949457&p=1pl&v=1&x=j7Bt1vgSPRlItSTnqkH9Rg","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:09:03+00:00","summary":"\/PRNewswire\/ -- Shilpa Gupta, Neeraj Agarwal, Oncology & Hematology Review, 2016;12(2):82-8, https:\/\/doi.org\/10.17925\/OHR.2016.12.02.82 (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology\u2026","author":{"name":"Wall Street Online Denmark","url":"http:\/\/www.wallstreet-online.de","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/836\/normal\/Screen_Shot_2016-01-27_at_11.09.05.png?1453892964"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929010162&p=1pl&v=1&x=iiRDYs3tx3kFBS8YMHocTw","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:18:30+00:00","summary":"\/PRNewswire\/ -- Shilpa Gupta, Neeraj Agarwal, Oncology & Hematology Review, 2016;12(2):82-8, https:\/\/doi.org\/10.17925\/OHR.2016.12.02.82 Sponsored by: Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY\u2026","author":{"name":"Ticker Tech","url":"http:\/\/www.tickertech.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/724\/normal\/Screen_Shot_2016-01-26_at_15.37.40.png?1453822700"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929024981&p=1pl&v=1&x=TQ8DStqmL75XWnyLvNiLvg","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:20:00+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"KHQ","url":"http:\/\/www.khq.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/658\/normal\/Screen_Shot_2016-01-26_at_12.10.14.png?1453810239"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929024987&p=1pl&v=1&x=4MWkaX0gFHI2Yq4tp2TNyQ","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:20:00+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"The State Journal","url":"http:\/\/www.statejournal.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/745\/normal\/Screen_Shot_2016-01-26_at_16.15.32.png?1453824964"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929026120&p=1pl&v=1&x=DxM1njonuW_NXHRvEgW_fA","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:21:07+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"KAIT-TV","url":"http:\/\/www.kait8.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/672\/normal\/Screen_Shot_2016-01-26_at_14.02.53.png?1453817085"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929038564&p=1pl&v=1&x=Q39imNX2jQ5roPH-0_700A","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:20:00+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"WISTV","url":"http:\/\/www.wistv.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/689\/normal\/Screen_Shot_2016-01-26_at_14.30.56.png?1453818748"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929038339&p=1pl&v=1&x=EBGToZcO2VWu_VcxQAV3dw","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:22:59+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"WLTZ","url":"http:\/\/www.wltz.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/653\/normal\/Screen_Shot_2016-01-26_at_12.04.16.png?1453809879"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929042041&p=1pl&v=1&x=t3E781r7FDSAU-DZYLvU1g","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:23:35+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"WMC Action News 5","url":"http:\/\/www.wmcactionnews5.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/727\/normal\/Screen_Shot_2016-01-26_at_15.42.23.png?1453822987"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929045298&p=1pl&v=1&x=rf4Y_Yui-Y6wzOfXtFUZFQ","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:24:06+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"WALB","url":"http:\/\/www.walb.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/647\/normal\/Screen_Shot_2016-01-26_at_11.47.02.png?1453808851"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929046930&p=1pl&v=1&x=gN0UZeI52KSwWQlt-OeLPA","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:20:00+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"WRCB- TV","url":"http:\/\/www.wrcbtv.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/690\/normal\/Screen_Shot_2016-01-26_at_14.32.42.png?1453818828"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929049412&p=1pl&v=1&x=Ofe3ya4ryaYUvPd2T5i9Pw","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:24:42+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"Cleveland 19","url":"http:\/\/www.cleveland19.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/683\/normal\/Screen_Shot_2016-01-26_at_14.20.50.png?1453818081"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929051386&p=1pl&v=1&x=bFXlECFb7XXcDr68CAMCWg","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:25:04+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"WTVM","url":"http:\/\/www.wtvm.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/646\/normal\/Screen_Shot_2016-02-02_at_14.58.13.png?1454425111"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929059870&p=1pl&v=1&x=923Cg3EieBdb8BsCQ9p-_Q","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:26:34+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"48 WAFF","url":"http:\/\/www.waff.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/699\/normal\/Screen_Shot_2016-01-26_at_14.47.41.png?1453819680"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929060304&p=1pl&v=1&x=sjhz3pXHcNv68opyl9FeRA","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:26:38+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"ABC 7 News KSWO","url":"http:\/\/www.kswo.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/708\/normal\/Screen_Shot_2016-01-26_at_15.08.58.png?1453821021"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929060692&p=1pl&v=1&x=67VTRViwDTQqAa2b1svaEA","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:26:41+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"WFMJ","url":"http:\/\/www.wfmj.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/701\/normal\/Screen_Shot_2016-01-26_at_14.49.34.png?1453819812"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929061725&p=1pl&v=1&x=0iHFchR_pAqBhzlkkpfxXg","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:26:50+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"WMBF News","url":"http:\/\/www.wmbfnews.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/710\/normal\/Screen_Shot_2016-01-26_at_15.11.39.png?1453821128"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929062499&p=1pl&v=1&x=tBvJ0Yxz1ivRf13Fywy9WQ","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:26:55+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"Fox 14 News","url":"http:\/\/www.fox14tv.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/651\/normal\/Screen_Shot_2016-01-26_at_12.00.07.png?1453809650"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929072258&p=1pl&v=1&x=wdsWx4tYl1X_boiWFO8CCA","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:28:40+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"Fox Wilmington","url":"http:\/\/www.wsfx.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/740\/normal\/Screen_Shot_2016-01-26_at_16.09.52.png?1453824618"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929072440&p=1pl&v=1&x=kuZFVuLkDQlj4SXVWFFYJg","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:28:42+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"NBC12","url":"http:\/\/www.nbc12.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/702\/normal\/Screen_Shot_2016-01-26_at_14.51.21.png?1453819926"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929073074&p=1pl&v=1&x=7RezojwtUJuStU5w1d_lmg","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:20:00+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"News Channel","url":"http:\/\/www.kxxv.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/645\/normal\/Screen_Shot_2016-01-26_at_11.42.27.png?1453808595"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929074056&p=1pl&v=1&x=nUJRf7ENenlD5gR1B-qCnA","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:29:02+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"KLTV","url":"http:\/\/www.kltv.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/704\/normal\/Screen_Shot_2016-01-26_at_14.54.15.png?1453820113"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929075970&p=1pl&v=1&x=j7TIone0Q5TzCMhKJw5SZA","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:20:00+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"Hawaii News Now","url":"http:\/\/www.hawaiinewsnow.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/661\/normal\/Screen_Shot_2016-01-26_at_12.16.42.png?1453810633"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929076356&p=1pl&v=1&x=b3gQBbgnB3lvzpc02ba6CQ","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:29:26+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"Wave 3 News","url":"http:\/\/www.wave3.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/697\/normal\/Screen_Shot_2016-01-26_at_14.44.55.png?1453819521"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929076577&p=1pl&v=1&x=WWdg7OvsL-vdNDMaOvbAhA","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:29:28+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"WTOC","url":"http:\/\/www.wtoc.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/688\/normal\/Screen_Shot_2016-01-26_at_14.30.16.png?1453818642"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929076660&p=1pl&v=1&x=t6ZtRIklZdbgISP0fhm0Jg","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:29:29+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"NBC Right Now KNDU 25","url":"http:\/\/www.nbcrightnow.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/735\/normal\/Screen_Shot_2016-01-26_at_15.54.16.png?1453823699"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929077680&p=1pl&v=1&x=th3uL7M3s6om6jfm-Dq_sA","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:00:00+00:00","summary":"\/PRNewswire\/ -- Shilpa Gupta, Neeraj Agarwal, Oncology & Hematology Review, 2016;12(2):82-8, https:\/\/doi.org\/10.17925\/OHR.2016.12.02.82 (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology\u2026","author":{"name":"PR Newswire UK","url":"http:\/\/www.prnewswire.co.uk\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/894\/normal\/Screen_Shot_2016-01-27_at_14.12.41.png?1453903996"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929078296&p=1pl&v=1&x=uSI9mk514DV9KDvhKhAvCQ","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:29:49+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"WTOL","url":"http:\/\/www.wtol.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/662\/normal\/Screen_Shot_2016-01-26_at_12.19.14.png?1453810785"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929078552&p=1pl&v=1&x=_py4uaUcWz_-RtPWoCQbRw","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:20:00+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"WFLX Fox 29","url":"http:\/\/www.wflx.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/656\/normal\/Screen_Shot_2016-01-26_at_12.07.36.png?1453810094"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929078740&p=1pl&v=1&x=E-H0Mw_G0HVnn_xILDGH5g","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:29:55+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"WDRB","url":"http:\/\/www.wdrb.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/693\/normal\/Screen_Shot_2016-01-26_at_14.37.05.png?1453819066"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929084771&p=1pl&v=1&x=zvxGeOcv08_iQTG72WS8KA","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:30:51+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"CW: Richmond","url":"http:\/\/www.cwrichmond.tv","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/648\/normal\/Screen_Shot_2016-01-26_at_11.48.33.png?1453809040"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929093002&p=1pl&v=1&x=GSUH8iY_ohcomDzj-AG3Kw","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:20:00+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"KFVE The Home Team","url":"http:\/\/www.k5thehometeam.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/734\/normal\/Screen_Shot_2016-01-26_at_15.53.15.png?1453823633"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929093761&p=1pl&v=1&x=fuKVb7aDCr00sQwigzpf-A","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T07:27:11+00:00","summary":"LONDON, December 15, 2016 \/PRNewswire\/ -- Shilpa Gupta, Neeraj Agarwal, Oncology & Hematology Review, 2016;12(2):82-8, https:\/\/doi.org\/10.17925\/OHR.2016.12.02.82 (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in\u2026","author":{"name":"Bioportfolio","url":"http:\/\/www.bioportfolio.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/821\/normal\/Screen_Shot_2015-12-11_at_16.36.54.png?1449851849"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929096163&p=1pl&v=1&x=1kXoSPKtnzu8CLOVvmbAvQ","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:32:25+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"14 News","url":"http:\/\/www.14news.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/696\/normal\/Screen_Shot_2016-01-26_at_14.43.50.png?1453819462"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929101437&p=1pl&v=1&x=luFZbYXGm2ztuI02Ip3odg","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:33:17+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"Tucson News Now","url":"http:\/\/www.tucsonnewsnow.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/812\/normal\/Screen_Shot_2016-01-27_at_10.13.49.png?1453889665"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929102827&p=1pl&v=1&x=FwSccaXonRxwJZO9PQBXNA","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:20:00+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"ABC 40","url":"http:\/\/www.abc40.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/698\/normal\/Screen_Shot_2016-01-26_at_14.45.46.png?1453819612"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929105358&p=1pl&v=1&x=SNK3UB7AApn3LG3N3-BxjQ","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:34:01+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"KTEN","url":"http:\/\/www.kten.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/643\/normal\/Screen_Shot_2016-01-26_at_11.36.58.png?1453808251"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929111387&p=1pl&v=1&x=XLJusavCdBRRLUcKnQlW-A","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:34:59+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"NewsWest9","url":"http:\/\/www.newswest9.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/703\/normal\/Screen_Shot_2016-01-26_at_14.52.45.png?1453820009"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929111857&p=1pl&v=1&x=KAIyIef_vJAaUiai6djy9w","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:35:05+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"WBOC 16","url":"http:\/\/www.wboc.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/717\/normal\/Screen_Shot_2016-01-26_at_15.23.21.png?1453821908"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929113355&p=1pl&v=1&x=DT0Z7sTM9p8JrjVhJVsaxQ","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:20:00+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"News 9","url":"http:\/\/www.news9.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/691\/normal\/Screen_Shot_2016-01-26_at_14.34.55.png?1453818924"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929121611&p=1pl&v=1&x=29D_fl4i2CQejEOWE_Rvlw","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:20:00+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"WSFA ","url":"http:\/\/www.wsfa.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/644\/normal\/Screen_Shot_2016-01-26_at_11.40.39.png?1453808470"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929122130&p=1pl&v=1&x=RoH2yEgxt-2de1T3KSqJIw","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:36:36+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"WLOX","url":"http:\/\/www.wlox.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/657\/normal\/Screen_Shot_2016-01-26_at_12.08.48.png?1453810156"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929126823&p=1pl&v=1&x=uirEHomiA5NWONiUlHDJDg","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:37:18+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"Kuam","url":"http:\/\/www.kuam.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/667\/normal\/Screen_Shot_2016-01-26_at_13.48.34.png?1453816300"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929127176&p=1pl&v=1&x=j38Wjie8x0tr7mVZUMluMw","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:37:21+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"KSLA News 12","url":"http:\/\/www.ksla.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/709\/normal\/Screen_Shot_2016-01-26_at_15.10.50.png?1453821079"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929151657&p=1pl&v=1&x=KEWYsYx9S2ABxvB0saYq4g","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:20:00+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"WAND 17","url":"http:\/\/www.wandtv.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/694\/normal\/Screen_Shot_2016-01-26_at_14.41.02.png?1453819294"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929154268&p=1pl&v=1&x=_b07qXklhWG4pH2yilNPJQ","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:41:47+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"South Carolina News Now","url":"http:\/\/www.live5news.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/730\/normal\/Screen_Shot_2016-01-26_at_15.47.02.png?1453823263"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929158266&p=1pl&v=1&x=R2l9Fyp4ZiHGY4R3lLoSUQ","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:42:26+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"KUSI News","url":"http:\/\/www.kusi.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/663\/normal\/Screen_Shot_2016-01-26_at_13.26.05.png?1453815145"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929159748&p=1pl&v=1&x=PBw3sr2dPURxt_0K8jRIAw","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:20:00+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"News Channel 6","url":"http:\/\/www.newschannel6now.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/652\/normal\/Screen_Shot_2016-01-26_at_12.01.23.png?1453809711"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929160665&p=1pl&v=1&x=lTY_dbRkVFuT1BTkZXDoCQ","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:42:48+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"KTRE","url":"http:\/\/www.ktre.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/705\/normal\/Screen_Shot_2016-01-26_at_15.04.21.png?1453820750"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929161065&p=1pl&v=1&x=RYqUQ_l17exgGlfLLnfxuw","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:42:53+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"NewsOn6","url":"http:\/\/www.newson6.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/677\/normal\/Screen_Shot_2016-01-26_at_14.12.15.png?1453817572"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929165366&p=1pl&v=1&x=AokGw6bThxWYzSPXo0yz_g","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:20:00+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"KLKN-TV Eyewitness News","url":"http:\/\/www.klkntv.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/655\/normal\/Screen_Shot_2016-01-26_at_12.06.08.png?1453810028"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929166977&p=1pl&v=1&x=-9Rdq1GT7t7ymKakiFtPmg","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:43:55+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"CBS8","url":"http:\/\/www.cbs8.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/681\/normal\/Screen_Shot_2016-01-26_at_14.17.19.png?1453817863"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929205834&p=1pl&v=1&x=EZB07ewKTXxlc01Y4C7uhA","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:49:46+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"Mississippi News Now ","url":"http:\/\/www.msnewsnow.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/649\/normal\/Screen_Shot_2016-01-26_at_11.57.00.png?1453809440"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28930703992&p=1pl&v=1&x=z5_i4TQmroblZmwsF1Riyw","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T16:43:10+00:00","summary":"\/PRNewswire\/ \u2014 Shilpa Gupta, Neeraj Agarwal, Oncology & Hematology Review, 2016;12(2):82-8, https:\/\/doi.org\/10.17925\/OHR.2016.12.02.82 (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review\u2026","author":{"name":"Fresh News","url":"http:\/\/www.freshnews.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/833\/normal\/Screen_Shot_2016-01-27_at_10.59.49.png?1453892431"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929063022&p=1pl&v=1&x=QoGwAzOOXyyQaD47qcxnTg","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:27:00+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"WDAM - TV","url":"http:\/\/www.wdam.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/682\/normal\/Screen_Shot_2016-01-26_at_14.19.46.png?1453818016"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929076312&p=1pl&v=1&x=9JG9AvijKJzSxFqYSCZKEw","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:29:25+00:00","summary":"SOURCE touchONCOLOGY.com LONDON Shilpa Gupta (Logo: http:\/\/photos.prnewswire.com\/prnh\/20151014\/276718LOGO ) Published recently in Oncology & Hematology Review, the peer-reviewed journal from touchONCOLOGY, Shilpa Gupta The full peer-reviewed, open-acc\u2026","author":{"name":"KPLC 7 News","url":"http:\/\/www.kplctv.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/641\/normal\/Screen_Shot_2016-01-26_at_11.30.17.png?1453807834"}},{"title":"New Review of Cancer Immunotherapy With Interleukin-2- Current Status and Future Developments","url":"http:\/\/ct.moreover.com\/?a=28929154062&p=1pl&v=1&x=W_kksANxWIwz4Hi-RN6cUQ","license":"public","citation_ids":[14766424,14766424],"posted_on":"2016-12-15T12:41:44+00:00","summary":"Information contained on this page is provided by an independent third-party content provider.","author":{"name":"2 News","url":"http:\/\/www.ktvn.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/654\/normal\/Screen_Shot_2016-01-26_at_12.05.19.png?1453809947"}}]}}